Compounds
Every compound, attributed: what creators claim, what the evidence shows, the dangers, and the legal status.
Every compound page follows the same honest structure: what it is, what creators claim (attributed to named speakers), what the evidence actually shows, which delivery forms it is discussed in, the dangers on record, and its legal status — date-stamped. We publish no dosing, protocol, or sourcing information. Start with the six peptides at the center of the October 30, 2026 federal policy moment:
BPC-157
A synthetic fragment modeled on a gastric protective protein — the most talked-about healing peptide in the world.
Go →Epitalon
A synthetic bioregulator peptide (tetrapeptide) marketed around telomeres and sleep — the Russian-research lineage entry in the six.
Go →KPV
A three-amino-acid fragment of alpha-MSH — the anti-inflammatory closer in the GLOW/KLOW stack family.
Go →MOTS-c
A mitochondrial-derived peptide — the metabolic entry in the federal six.
Go →Semax
A heptapeptide developed in Russia as a nootropic/stroke drug there — sold in the US as a nasal spray by creators and clinics.
Go →TB-500
A fragment of thymosin beta-4, a peptide found naturally in injured tissue — the 'foreman' of the healing stacks.
Go →